The 2026 SelectUSA Investment Summit marked a milestone in U.S.– India economic ties, as Indian industry leaders announced $20.5 billion in new investments across the United States. The commitments highlight India’s growing role as a strategic partner in the American economy, spanning pharmaceuticals, advanced manufacturing, energy infrastructure, and emerging technologies....
Dr. Reddy’s, Bayer, Partner to Market Heart Drug in India
Hyderabad, India-based Dr. Reddy's Laboratories Ltd. and Bayer have entered into a partnership to market and distribute a second brand of the drug Vericiguat in India. Under the agreement, Bayer has granted non-exclusive rights to Dr. Reddy's to sell Vericiguat under the brand name Gantra. Vericiguat is a soluble guanylate...
Dr.Reddys, Prestige BioPharma to Supply Herceptin Biosimilar
Hyderabad, India-based Dr. Reddy's Laboratories Ltd., and Prestige BioPharma Ltd., a Singapore-based firm, entered into an exclusive partnership for the supply and commercialization of the latter's proposed Trastuzumab biosimilar, in select countries. Trastuzumab (HD201) is a proposed biosimilar to Roche’s Herceptin and can be prescribed for the treatment of HER2...